Infection and Immunity, November 2001, p. 7182-7186, Vol. 69, No. 11
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.11.7182-7186.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Mycobacterium ulcerans Cytotoxicity
in an Adipose Cell Model
Karen M.
Dobos,1,*
Pamela L.
Small,2
Manon
Deslauriers,3
Fredrick D.
Quinn,3 and
C. Harold
King1
Department of Medicine, Emory University
School of Medicine, Emory University, Atlanta, Georgia
303031; Department of Microbiology,
University of Tennessee, Knoxville, Tennessee
379962; and Division of AIDS, STD,
and TB Laboratory Research, National Center for Infectious
Diseases, Centers for Disease Control and Prevention,
Atlanta, Georgia 303333
Received 31 May 2001/Returned for modification 10 July
2001/Accepted 10 August 2001
 |
ABSTRACT |
An adipose cell (SW872) model was developed to observe cellular
necrosis and apoptosis upon Mycobacterium ulcerans
infection and treatment with mycobacterial exudate. Apoptosis was
likely due to secreted proteins, while necrosis was likely due to
mycolactone. Our data suggest that additional factors in
M. ulcerans may be involved in Buruli
ulcer pathogenesis.
 |
TEXT |
Buruli ulcer (BU) disease, caused by
Mycobacterium ulcerans infection, is characterized by
chronic necrotizing skin ulcers, with tissue destruction often observed
in the adipose tissue and at sites distal to acid-fast bacilli. Based
on these observations, the pathogenesis of BU has been hypothesized to
be due to one or more secreted mycobacterial toxins. Early studies on
the elucidation of a toxin led to the description of a heat-stable and
pronase- and lipase-labile factor from the culture filtrate of
M. ulcerans (10). Further studies
revealed that M. ulcerans filtrates possessed immunosuppressive properties (16). The advent of more
sensitive biochemical methods led to the identification and
characterization of a unique polyketide in M. ulcerans, named mycolactone, which possesses distinct
cytotoxic and immunosuppressive characteristics (4-6,
15).
A perusal of the literature demonstrates that previous studies of the
cytotoxicity of M. ulcerans culture filtrate
(MUCF) relied upon albumin- or serum-supplemented media. The high
protein content of such media impeded the characterization of the
secreted proteins of M. ulcerans, including their
role, if any, in cytotoxicity. Recent developments in the culture of
M. ulcerans in protein-free media have led to the
discovery of serodiagnostic proteins (1) and
phospholipases (7, 8) in the MUCF and facilitated this study, in which a human adipose cell model of M. ulcerans infection and MUCF cytotoxicity was established.
M. ulcerans infection of human
adipose cells.
M. ulcerans strain 94-816 (kindly provided by Francoise Portaels) was grown by serial 10-fold
passage to 100 ml in Middlebrook 7H9 oleic
acid-albumin-dextrose-catalase broth until the optical density (600-nm
) was 0.5 to 0.7. Single-cell bacterial suspensions were made by
pulse sonication at 4°C using a Branson 450 cell sonicator fitted
with a cup horn attachment (Branson Ultrasonics, Danbury, Conn.).
Human adipose cells (SW872) were obtained from the American Type
Culture Collection (ATCC HTB 92; Manassas, Va.). Cells were maintained
in L-15S (Leibovitz-15 medium with L-glutamine [Gibco/BRL, Grand Island, N.Y.], supplemented with 10% heat-inactivated fetal bovine serum [HyClone Laboratories Inc., Logan, Utah] and sodium bicarbonate [1.5 g/liter; Gibco]) and incubated at 37°C and
5% CO2. Prior to use in experimental assays, the
cells were released from the culture flask with 0.25% trypsin (Gibco),
washed twice with fresh medium, and seeded onto 6- or 24-well
microculture plates as needed. Viable cell counts were confirmed prior
to each experiment using trypan exclusion (13).
For electron microscopic (EM) analysis, fresh SW872 cells were
trypsinized (0.25.%), washed twice, and adjusted to the desiredThis study was supported in part by a grant from the Department of
Health and Human Services, U50/CC416560-01.
We acknowledge Kristine Birkness at the Centers for Disease Control and
Prevention for her contribution to the preliminary tissue culture
studies and the Emory University Microscopy Core for processing the
samples for EM analysis.
| 1.
|
Dobos, K. M.,
E. A. Spotts,
B. J. Marston,
C. R. Horsburgh, Jr., and C. H. King.
2000.
Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer disease.
Emerg. Infect. Dis.
6:158-164[Medline].
|
| 2.
|
Dobos, K. M.,
E. A. Spotts,
F. D. Quinn, and C. H. King.
2000.
Necrosis of lung epithelial cells during infection with Mycobacterium tuberculosis is preceded by cell permeation.
Infect. Immun.
68:6300-6310[Abstract/Free Full Text].
|
| 3.
|
Fischer, L. J.,
F. D. Quinn,
E. H. White, and C. H. King.
1996.
Intracellular growth and cytotoxicity of Mycobacterium haemophilum in a human epithelial cell line (Hec-1-B).
Infect. Immun.
64:269-276[Abstract].
|
| 4.
|
George, K. M.,
L. P. Barker,
D. M. Welty, and P. L. Small.
1998.
Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans.
Infect. Immun.
66:587-593[Abstract/Free Full Text].
|
| 5.
|
George, K. M.,
D. Chatterjee,
G. Gunawardana,
D. Welty,
J. Hayman,
R. Lee, and P. L. Small.
1999.
Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.
Science
283:854-857[Abstract/Free Full Text].
|
| 6.
|
George, K. M.,
L. Pascopella,
D. M. Welty, and P. L. Small.
2000.
A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells.
Infect. Immun.
68:877-883[Abstract/Free Full Text].
|
| 7.
|
Gomez, A.,
A. Mve-Obiang,
B. Vray,
J. Remacle,
K. Chemlal,
W. M. Meyers,
F. Portaels, and P. A. Fonteyne.
2000.
Biochemical and genetic evidence for phospholipase C activity in Mycobacterium ulcerans.
Infect. Immun.
68:2995-2997[Abstract/Free Full Text].
|
| 8.
|
Gomez, A.,
A. Mve-Obiang,
B. Vray,
W. Rudnicka,
I. C. Shamputa,
F. Portaels,
W. M. Meyers,
P. A. Fonteyne, and L. Realini.
2001.
Detection of phospholipase C in nontuberculous mycobacteria and its possible role in hemolytic activity.
J. Clin. Microbiol.
39:1396-1401[Abstract/Free Full Text].
|
| 9.
|
Hayman, J.
1993.
Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection.
J. Clin. Pathol.
46:5-9[Free Full Text].
|
| 10.
|
Hockmeyer, W. T.,
R. E. Krieg,
M. Reich, and R. D. Johnson.
1978.
Further characterization of Mycobacterium ulcerans toxin.
Infect. Immun.
21:124-128[Abstract/Free Full Text].
|
| 11.
|
Horsburgh, C. R., Jr., and W. M. Meyers.
1997.
Buruli ulcer, p. 119-134.
In
C. R. Horsburgh, Jr., and A. M. Nelson (ed.), Pathology of emerging infections. ASM Press, Washington, D.C.
|
| 12.
|
Lai, X. H.,
I. Arencibia,
A. Johansson,
S. N. Wai,
J. Oscarsson,
S. Kalfas,
K. G. Sundqvist,
Y. Mizunoe,
A. Sjostedt, and B. E. Uhlin.
2000.
Cytocidal and apoptotic effects of the ClyA protein from Escherichia coli on primary and cultured monocytes and macrophages.
Infect. Immun.
68:4363-4367[Abstract/Free Full Text].
|
| 13.
|
Mehta, P. K.,
C. H. King,
E. H. White,
J. J. Murtagh, Jr., and F. D. Quinn.
1996.
Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication.
Infect. Immun.
64:2673-2679[Abstract].
|
| 14.
|
Mve-Obiang, A.,
J. Remacle,
J. C. Palomino,
A. Houbion, and F. Portaels.
1999.
Growth and cytotoxic activity by Mycobacterium ulcerans in protein-free media.
FEMS Microbiol. Lett.
181:153-157[CrossRef][Medline].
|
| 15.
|
Pahlevan, A. A.,
D. J. Wright,
C. Andrews,
K. M. George,
P. L. Small, and B. M. Foxwell.
1999.
The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function.
J. Immunol.
163:3928-3935[Abstract/Free Full Text].
|
| 16.
|
Pimsler, M.,
T. A. Sponsler, and W. M. Meyers.
1988.
Immunosuppressive properties of the soluble toxin from Mycobacterium ulcerans.
J. Infect. Dis.
157:577-580[Medline].
|
| 17.
|
Ramakrishnan, L., and S. Falkow.
1994.
Mycobacterium marinum persists in cultured mammalian cells in a temperature-restricted fashion.
Infect. Immun.
62:3222-3229[Abstract/Free Full Text].
|
| 18.
|
Read, J. K.,
C. M. Heggie,
W. M. Meyers, and D. H. Connor.
1974.
Cytotoxic activity of Mycobacterium ulcerans.
Infect. Immun.
9:1114-1122[Abstract/Free Full Text].
|
| 19.
|
Sonnenberg, M. G., and J. T. Belisle.
1997.
Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry.
Infect. Immun.
65:4515-4524[Abstract].
|
| 20.
|
Tsang, A. Y., and E. R. Farber.
1973.
The primary isolation of Mycobacterium ulcerans.
Am. J. Clin. Pathol.
59:688-692[Medline].
|